AXA
French insurance group and one of the world's largest institutional asset owners. Named by the UN Special Rapporteur on the occupied Palestinian territory on 30 June 2025 as investing at least USD 4.09 billion in companies tracked in her report, and as an insurer whose policies 'underwrite the risks other companies necessarily take when operating in Israel and the occupied Palestinian territory' (A/HRC/59/23, para. 76). Divested fully from Elbit Systems by the end of 2019 and from five Israeli banks by 24 June 2024 under sustained campaigning, but has never published the policy that governed either decision. AFSC Investigate recorded more than USD 177 million in twelve weapons manufacturers on the BDS divestment shortlist as of 1 May 2026. AXA completed the sale of its asset manager, AXA Investment Managers, to BNP Paribas on 1 July 2025.
Take Action
Apply pressure where it matters. Use these tools and personalise your message with evidence from this page.
- Write to AXATemplates for policyholders, pension savers and institutional clients anywhere in the world. The strongest single ask is for a published policy, not another portfolio move
- Report New IntelligenceAXA's underwriting book is the biggest gap in this profile. Policy documents, broker slips and renewal terms naming arms manufacturers or operations in the occupied territories are the intelligence we most need
- Share on LinkedInShare with risk, pensions and procurement contacts
- View Strategic AnalysisWhat the divestments did and did not cover, and the 15 September 2026 strategic plan window
Before taking action, review our Code of Conduct for professional standards and ethical guidelines.
Help Us Hold AXA Accountable
Your skills and knowledge can strengthen this campaign. Join our volunteer research team or share insider information securely.
Leverage Your Expertise
Do you work in this sector? We need professionals who understand procurement cycles, regulatory compliance, and corporate governance. Don't just boycott - lead!
Decision-Maker Directory
Key individuals with influence over corporate partnerships and procurement decisions. The contact details shown are published business addresses, listed for professional correspondence only. Write to the role, not the person, and keep correspondence courteous and factual. Repeated, abusive or personal contact is unlawful harassment and damages the case being made.
Material Risk Framing
Frame your message around business risks. These talking points resonate with corporate stakeholders and institutional investors.
AXA has commercial ties with Israel through its securities holdings and its underwriting book. The ICJ found Israel's continued presence in the occupied Palestinian territory unlawful on 19 July 2024 and settlements and their associated economic activity contrary to international law; on 26 January 2024 it found a real and imminent risk to the right of Palestinians in Gaza to be protected from acts of genocide and ordered Israel to prevent them; and the UN Commission of Inquiry concluded in September 2025 that genocide is being committed in Gaza (A/HRC/60/CRP.3). As a French société anonyme above the employee thresholds, AXA falls within the loi de vigilance of 27 March 2017, which requires a published vigilance plan identifying and mitigating severe human rights impacts across its activities and business relationships, a duty enforceable by third parties before the French courts.
AXA sells retail and commercial insurance in around 50 markets and markets itself on responsible investment across more than EUR 450 billion of assets. It is one of only two insurers named in the UN Special Rapporteur's June 2025 report. It has also moved twice under campaign pressure (Elbit Systems by the end of 2019, five Israeli banks by June 2024), which establishes that the pressure works and makes each subsequent refusal harder to explain. Ekō asked AXA on 24 July 2024 which policy had governed the bank divestment and reported no reply as of 20 August 2024.
AXA reported gross written premiums and other revenues of EUR 66.3 billion and underlying earnings of EUR 4.5 billion for the first half of 2026, with a Solvency II ratio of 218%. The sums at issue are trivial against that balance sheet: USD 177 million of weapons holdings is a rounding error, and the USD 20.4 million of Israeli bank shares was sold without visible cost. Divestment should therefore be argued as exclusion on principle and as fiduciary and vigilance-law risk, never as an attempt to move the share price.
AXA completed the disposal of AXA Investment Managers to BNP Paribas on 1 July 2025, so the manager that held most of the documented positions is no longer part of the group; AFSC Investigate records that AXA nonetheless retains control over asset allocation. The general account backing policyholder reserves remains AXA's own. Since 1 December 2025 finance, strategy, underwriting, risk and technology have reported to a single executive, Guillaume Borie, which puts the investment and underwriting questions in one office. Insurance contracts renew annually, so underwriting guidelines can be changed at each renewal.
Product Alternatives
Ethical replacements tagged by what matters to you: cost, quality, ethics, sustainability, or local sourcing. Make the switch today.
French Mutual Insurers
Member-owned mutual insurers with stronger ethical standards than shareholder-owned companies
French mutual insurer with strong ethical stance, member-owned cooperative model. Excludes weapons manufacturers and fossil fuels from investments.
France's leading ethical insurer. Member-owned mutual. Certified B Corp. Strong responsible investment policy excluding controversial weapons.
French mutual insurer with cooperative ownership model and social responsibility commitments.
Member-owned mutual. Part of the social economy movement. Full range of insurance products including home, auto, and life.
European Ethical Insurers
Insurance providers with documented ethical investment policies
B-Corp certified insurer with ethical investment policy and transparent business model.
Public Benefit Corporation. Gives back programme donates to causes. Digital-first model. Verify current European availability.
UK Ethical Insurance
For those seeking UK-based ethical insurance alternatives
Comparison Legend
Strategic Analysis
In-depth assessment of the company's position, vulnerabilities, and recommended approaches for effective engagement.
High severity, high vulnerability — campaigns with the best chance of making an impact
Severity
6.0/10
(6 + 6) ÷ 2 = 6.0
Strategic Vulnerability
8.0/10
(8 + 8) ÷ 2 = 8.0
Learn about our methodology — companies are categorised based on severity (harm potential) vs strategic vulnerability (campaign leverage).
Why do these scores change?
Unlike static boycott lists, our targeting model is dynamic. This company's position on the matrix is re-evaluated continually as we verify new contracts, divestments, or policy changes. Your reporting directly impacts this score.
AXA is one of Europe's largest insurers, and there are two separate cases against it. It invests money in companies involved in the occupation, and it has already sold some of those holdings under pressure, which proves campaigning works on this company. The second case is the one nobody has pressed. AXA sells insurance, nothing large operates without insurance, and it has never said what it will and will not cover.
Key Leverage Points
- Ask what AXA insures, in writing, at renewal. If you hold an AXA policy (home, car, business, or a workplace pension), ask what its rules say about covering companies that operate in illegal Israeli settlements. It has never published an answer, and declining to answer a paying customer costs it something.
- Ask for a rule, not another sale. AXA has sold these holdings twice under pressure and published no policy either time. A portfolio can quietly change back; a published exclusion has to be formally repealed. That is the ask that costs the company something.
- Write to the right company. AXA sold its investment arm to BNP Paribas in July 2025, so letters about "AXA IM's funds" now get a truthful brush-off. Ask instead about the money AXA holds to back its own policies, which is still AXA's own.
- September 2026 is a dated opportunity. AXA publishes its 2027–2029 strategic plan on 15 September 2026, its first since that sale, and a strategic plan is where commitments get drafted. The next shareholders' meeting follows in spring 2027.
- French law already requires a published plan. Since 2017, large French companies must publish a "vigilance plan" covering serious human rights harms across their activities and business relationships, and outsiders can enforce it in the French courts. Insurance is a business relationship. The plan is public: read it against what the UN found.
Evidence Summary
The UN Special Rapporteur on the occupied Palestinian territory is an independent expert appointed by the UN Human Rights Council to investigate and report. A report published in June 2025 named AXA twice. It found that AXA still invests at least $4.09 billion in companies the report tracks, "despite some divestment decisions", and that policies written by AXA and Allianz "de-risk" the environment for companies operating in Israel and the occupied territory.
The divestments were real, and campaigning won them. Research by the firm Profundo, using six quarters of market data, shows AXA holding more than 2.5 million shares worth $20.4 million in Bank Hapoalim, Bank Leumi and Israel Discount Bank until September 2023, and effectively none by June 2024. It had held nothing in Elbit Systems, Israel's largest weapons manufacturer, since the end of 2019. Profundo reads the sales as tracking the campaign rather than the share prices, which were steady or rising. That is as clean a demonstration of a working pressure campaign as this directory contains.
What the sales did not cover is equally precise. AXA held $150.43 million in eleven weapons manufacturers as at 30 June 2024, and $134.91 million in thirteen making weapons that include depleted uranium munitions, holdings the researchers say breach AXA's own policy on controversial weapons. AFSC Investigate still recorded more than $177 million across twelve weapons companies in May 2026. When the campaign group Ekō wrote in July 2024 asking which policy had governed the bank sales, it reported receiving no reply.
That is the pattern: AXA sells when pressed, and publishes no rule. On insurance it publishes nothing at all. No public source names a specific policy AXA writes for an arms manufacturer or for an operation in the occupied territories, because AXA does not disclose what it underwrites. The opacity is the finding (sources).
Engagement Strategy
AXA is not an Israeli company, so there is no contract to cancel and no procurement to refuse. The routes are those of a customer, a client or a shareholder, and they exist in every country AXA operates in.
- Policyholders and pension savers. Put the underwriting question in writing at renewal, anywhere in the world.
- Institutional clients and shareholders. Press for a published exclusion policy rather than another portfolio shift, and put it at the annual meeting.
- Legal and regulatory. The French vigilance plan is public and enforceable by outsiders. Read it against what the UN found, and say where it falls short.
Throughout, ask for a rule and for disclosure: what AXA will not underwrite, and what it will not hold. It has shown it will sell under pressure, and equally that it will not say why.
Evidence & Sources
Verified sources including NGO reports, regulatory filings, and primary documents. Use these to substantiate your correspondence. Entries marked First-hand were reported directly to this site and are published without identifying the source.
Gross written premiums and other revenues of EUR 66.3 billion, up 5%; underlying earnings of EUR 4.5 billion, up 4% and up 9% excluding AXA IM; underlying earnings per share of EUR 2.19; Solvency II ratio of 218% at 30 June 2026. States that 'AXA completed the disposal of its Asset Management business (AXA IM) to BNP Paribas on July 1, 2025', which is why comparatives are restated. Thomas Buberl is quoted as chief executive and announces that a new strategic plan for 2027-2029 will be presented on 15 September 2026.
Open sourceThe most recent register entry, stated to be valid as of 1 May 2026. Records that AXA Investment Managers invests more than USD 177 million in twelve weapons companies on the BDS divestment shortlist (BAE Systems, Boeing, Caterpillar, General Dynamics, Honeywell International, L3Harris, Leonardo, Lockheed Martin, Northrop Grumman, Oshkosh, Rolls-Royce and Textron), with the underlying data compiled before BNP Paribas's acquisition. Records the past divestments from Elbit Systems at the end of 2019 and from five Israeli banks between 2022 and 2024, and states that 'BNP Paribas acquired AXA Investment Managers in July 2025. As part of the acquisition, AXA maintains control over asset allocation.'
Open sourceAXA's 2026 annual shareholders' meeting was held on 30 April 2026 at 2.30pm CEST, with share registration closing on 23 April 2026. Records the company's own timetable for the annual meeting, the forum at which shareholders have raised the arms holdings in previous years; the next such meeting falls in spring 2027.
Open sourceThe current edition of the register most relevant to European financial institutions. Researched by Profundo, it screens 104 businesses and identifies 1,115 European financial institutions with relationships to them, USD 310 billion in loans and underwriting between January 2023 and August 2025, and USD 1,503 billion in shares and bonds held at 31 August 2025. AXA's individual position in this edition has not been extracted here; the UN Special Rapporteur's June 2025 report sources its USD 4.09 billion figure in part to the coalition's 2024 dataset.
Open sourceEffective 1 December 2025, Guillaume Borie moves from chief executive of AXA France to Global Head of Finance, Strategy, Underwriting, Risk and Technology, reporting to the Group CEO; Mathieu Godart becomes chief executive of AXA France; Karima Silvent becomes Deputy General Secretary; Matthieu Caillat, previously chief operating officer of AXA XL, becomes Group Chief Technology and AI Officer. Frédéric de Courtois and Alexander Vollert step down as senior advisers. Establishes that investment and underwriting policy now sit within a single executive remit.
Open sourceThe Commission concluded on reasonable grounds that Israeli authorities and security forces have committed and continue to commit acts of genocide against Palestinians in Gaza, that they have had and continue to have genocidal intent, and that the State of Israel bears responsibility for the failure to prevent genocide, the commission of genocide and the failure to punish genocide. The analysis covers Gaza only, between 7 October 2023 and 31 July 2025.
Open sourceThe single most important source on this page, and the only one that addresses AXA as an insurer rather than only as an investor. Paragraph 76, verbatim: 'Global insurance companies, including Allianz and AXA, also invest large sums in shares and bonds implicated in the occupation and genocide, partly as capital reserves for policyholder claims and regulatory requirements, but primarily to generate returns. Allianz holds at least $7.3 billion and AXA, despite some divestment decisions, still invests at least $4.09 billion in tracked companies named in the present report. Their insurance policies also underwrite the risks other companies necessarily take when operating in Israel and the occupied Palestinian territory, thus enabling the commission of human rights abuses and "de-risking" the operational environment.' The report's footnotes source the USD 4.09 billion figure to 13F filings and the Don't Buy Into Occupation 2024 dataset, and the phrase 'despite some divestment decisions' to Ekō's report on the Israeli bank divestment. The report is illustrative rather than exhaustive: it says over 45 entities named were informed of the allegations and 15 replied.
Open sourceAt AXA's shareholders' meeting in Paris a shareholder challenged executives over the group's investments in arms manufacturers supplying Israel, while campaigners protested outside the venue. The article cites USD 173.62 million across fourteen arms companies, over USD 150 million in firms supplying arms used in Gaza, and USD 135 million in companies producing depleted uranium, white phosphorus and nuclear arms. It records no response from AXA executives.
Open sourceFound AXA holds $176.7M in arms companies supplying Israel, contributing to $1.7B total from major insurers including Allianz, Aviva, and Zurich. The campaign's underlying report, 'Ensuring Genocide', is cited by the UN Special Rapporteur in A/HRC/59/23 in support of the finding that insurers' policies de-risk the operational environment for companies operating in Israel and the occupied Palestinian territory.
Open sourceAs at 30 June 2024 AXA held USD 150.43 million (USD 78.87 million in shares and USD 71.56 million in bonds) in eleven companies arming Israel: Rolls-Royce, GE Aerospace, Honeywell, Textron, Boeing, Lockheed Martin, General Dynamics, Northrop Grumman, RTX, L3Harris and BAE Systems. The report further finds holdings of USD 173.62 million across at least fourteen weapons manufacturers, of which USD 134.91 million sits in thirteen companies producing controversial weapons including nuclear arms, white phosphorus and depleted uranium, which the researchers state breaches AXA's own controversial weapons policy. AXA publishes a controversial weapons policy and a group responsible investment policy; it is not quoted in the report.
Open sourceDBIO ranks AXA 22nd among top 100 European investors in Israeli settlement enterprise with $1.449B invested in companies involved in settlements.
Open sourceThe primary record of what the bank divestment actually covered. Research by Jeroen Walstra of Profundo, commissioned by Ekō and delivered on 28 June 2024, using Refinitiv data across six quarters from 31 December 2022 to 24 June 2024. Findings: until 30 September 2023 AXA held more than 2.5 million shares worth USD 20.4 million in Bank Hapoalim, Bank Leumi and Israel Discount Bank; by 24 June 2024 its holdings had effectively dropped to zero, with a residual 16,920 Bank Leumi shares (USD 130,000) that Profundo attributed to reporting and internal accounting delays and treated as full divestment; AXA had held nothing in Mizrahi-Tefahot or First International Bank of Israel since at least 31 December 2022. Profundo records that AXA did not sell in response to share prices, which were steady or rising, but in response to external pressure. Ekō contacted AXA on 24 July 2024 to ask which policy had governed the decision, and states it had received no response as of 20 August 2024.
Open sourceThe campaign announcement of the divestment confirmed by the Ekō and Profundo research: 2.5 million shares worth USD 20.4 million in Bank Hapoalim, Bank Leumi and Israel Discount Bank sold between 30 September 2023 and 24 June 2024, following the earlier full divestment from Elbit Systems by the end of 2019. The coalition, 'Stop AXA Assistance to Israeli Apartheid', has campaigned since 2016.
Open sourceThe International Court of Justice found Israel's continued presence in the occupied Palestinian territory unlawful, held settlements and their associated economic activity contrary to international law, and set out obligations on states in relation to dealings with settlements. The legal framework on which exclusion, vigilance-plan and underwriting decisions rest, and the opinion cited by Ekō in its correspondence with AXA.
Open sourceThe earlier baseline against which the divestments should be read. By August 2022 AXA held USD 15.6 million across four Israeli banks (Bank Hapoalim USD 6.53 million, Bank Leumi USD 5.63 million, Israel Discount Bank USD 3.08 million and Mizrahi Tefahot USD 600,000), up from USD 6 million across two banks in May 2021, so its exposure was rising, not falling, before the campaign escalated. The same edition ranked AXA 24th among European investors with USD 957 million invested in other companies involved in the settlement enterprise, naming Caterpillar, Volvo Group, IBM, Siemens, Puma, Airbnb and Alstom.
Open sourceAXA's own position, recorded here so that its answer sits alongside the allegation. The company states that it applies a comprehensive responsible investment policy across more than EUR 450 billion of assets, that it has established dedicated policies for sectors with particularly sensitive environmental or ethical challenges, and that it is a signatory to the Principles for Responsible Investment. AXA also publishes a controversial weapons policy. It has not published any policy specific to Israel or the occupied Palestinian territory, and did not respond to Ekō's request of 24 July 2024 to identify the policy that governed its divestment from the five Israeli banks.
Open sourceUpdates & Milestones
- Half-year results and a strategic plan window
AXA reports first-half 2026 revenues of EUR 66.3 billion, underlying earnings of EUR 4.5 billion and a Solvency II ratio of 218%, and announces that a new strategic plan for 2027-2029 will be presented on 15 September 2026.
- Register position updated
AFSC Investigate's profile, valid as of 1 May 2026, records AXA Investment Managers holding more than USD 177 million in twelve weapons companies on the BDS divestment shortlist, and states that AXA retains control over asset allocation following BNP Paribas's acquisition.
- 2026 annual shareholders' meeting
AXA holds its annual shareholders' meeting on 30 April 2026 in Paris. The next meeting falls in spring 2027.
- Investment and underwriting placed under one executive
AXA announces that from 1 December 2025 Guillaume Borie, previously chief executive of AXA France, will lead finance, strategy, underwriting, risk and technology for the group, reporting to the Group CEO.
- AXA Investment Managers sold to BNP Paribas
AXA completes the disposal of its asset management business to BNP Paribas on 1 July 2025, as recorded in its own half-year 2026 earnings release. AFSC Investigate notes that AXA nonetheless retains control over asset allocation. The general account backing policyholder reserves remains AXA's own.
- Named by the UN Special Rapporteur
A/HRC/59/23, at paragraph 76, names AXA and Allianz as global insurers investing in shares and bonds implicated in the occupation and genocide, puts AXA's holdings in tracked companies at at least USD 4.09 billion despite its divestment decisions, and finds that their insurance policies underwrite the risks other companies necessarily take when operating in Israel and the occupied Palestinian territory, 'de-risking' the operational environment.
- Shareholder confrontation at AGM
Shareholders challenge AXA executives over arms manufacturer investments at Paris AGM. Campaigners protest outside the venue; Middle East Eye records no response from the executives.
- Insurance sector holdings quantified
The Boycott Bloody Insurance research puts AXA's holdings in arms companies supplying Israel at USD 176.7 million, within a total of USD 1.7 billion across major insurers including Allianz, Aviva and Zurich.
- Arms investments exposed
Eko/Profundo report reveals AXA holds $150M in 11 weapons manufacturers supplying Israel. The same research puts total holdings at USD 173.62 million across at least fourteen manufacturers, of which USD 134.91 million sits in thirteen companies producing controversial weapons including depleted uranium.
- Divestment confirmed, but no policy published
Ekō and Profundo publish the data confirming the divestment and, on 24 July 2024, ask AXA which policy governed it or whether it rested on a new, unpublished policy. Ekō states that as of 20 August 2024 it had received no response. The divestment therefore stands as a portfolio decision rather than a rule.
- ICJ finds the occupation unlawful
The International Court of Justice finds Israel's continued presence in the occupied Palestinian territory unlawful and holds settlements and their associated economic activity contrary to international law. Ekō cites the opinion in its correspondence with AXA.
- Israeli bank divestment complete
AXA sells remaining shares in Bank Hapoalim, Bank Leumi, and Israel Discount Bank. As at 24 June 2024 Profundo records a residual 16,920 Bank Leumi shares worth USD 130,000, which it attributes to reporting and internal accounting delays and treats as full divestment.
- CEO acknowledges zero Israeli bank holdings
At AGM, AXA CEO confirms company has 'zero' direct or indirect investments in Israeli banks.
- Still holds major Israeli bank shares
Eko research shows AXA still holds $20M+ in three Israeli banks despite ESG commitments. Profundo's quarterly series records the peak of AXA's position, 2,580,922 shares across the five banks screened, at 30 September 2023, after which it falls away.
- Divests from two Israeli banks
AXA divests from Bank Mizrahi-Tefahot and First International Bank of Israel. Profundo's data shows no holdings in either from 31 December 2022 onwards.
- Bank holdings rising, not falling
The Don't Buy Into Occupation coalition records AXA holding USD 15.6 million across four Israeli banks (Bank Hapoalim, Bank Leumi, Israel Discount Bank and Mizrahi Tefahot) against USD 6 million across two banks in May 2021. The same edition ranks AXA 24th among European investors with USD 957 million in other companies involved in the settlement enterprise.
- Full Elbit divestment completed
AXA completes full divestment from Elbit Systems, Israel's largest military contractor. AFSC Investigate records that AXA has not reinvested since.
- Partial Elbit divestment begins
AXA begins divesting from Elbit Systems following sustained BDS campaign pressure. A further partial divestment follows in March 2019.
- Divestment campaign launched
French organisations launch the 'Stop AXA Assistance to Israeli Apartheid' coalition, calling on AXA to divest from Elbit Systems and from the five largest Israeli banks financing settlement construction in the occupied Palestinian territory.